Relevant Publications Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals Development of passive immunity against SARSCoV-2 for management of immunodeficient patients—a perspective Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo Evolution of Antibody Immunity to SARS-CoV-2 Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice
